Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4545-4550, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role of Tumor Necrosis Factor Alpha,
Interleukin-1
, and Interleukin-6 in a Mouse Model of Group B
Streptococcal Arthritis
Luciana
Tissi,1,*
Manuela
Puliti,1
Roberta
Barluzzi,1
Graziella
Orefici,2
Christina
von Hunolstein,2 and
Francesco
Bistoni1
Microbiology Section, Department of
Experimental Medicine and Biochemical Sciences, University of Perugia,
06122 Perugia,1 and Laboratory of
Bacteriology and Medical Mycology, Istituto Supiore di Sanità,
Rome,2 Italy
Received 24 February 1999/Returned for modification 4 May
1999/Accepted 10 June 1999
Intravenous inoculation of CD1 mice with 107 CFU of
type IV group B Streptococcus (GBS IV) results in a high
incidence of diffuse septic arthritis. In this study the roles of tumor
necrosis factor alpha (TNF-
), interleukin-1
(IL-1
),
and IL-6 in articular pathology were evaluated. Cytokine levels were
quantified in the serum and joints by enzyme-linked immunosorbent assay
in mice injected with GBS IV and tested or not tested with
pentoxifylline (PTF), a methylxanthine that affects cytokine
production. PTF was administered intraperitoneally at a dose of 1 mg/mouse (50 mg/kg of body weight) 1 h after GBS infection and
then at 24-h intervals for 4 days. High levels of IL-1
and IL-6, but
not TNF-
, were detected in the joints of mice injected with GBS IV
from 5 to 15 days after infection, when articular lesions were most
frequent and severe. IL-1
and IL-6 concentrations in the
joints significantly (P < 0.001) exceeded those
detected in the serum, confirming a strong local production. PTF
treatment resulted in a strong reduction of cytokine production and in
a marked decrease in both the incidence and severity of arthritis.
Inoculation of exogenous murine recombinant IL-1
or IL-6 in mice
treated with GBS IV plus PTF resulted in an incidence and severity of
articular lesions similar to those obtained with inoculation of GBS IV
alone. No significant effect was obtained with TNF-
administration.
These data show a strong involvement of IL-1
and IL-6, but not
TNF-
, in the pathogenesis of GBS arthritis.
*
Corresponding author. Mailing address: Microbiology
Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, 06122 Perugia, Italy. Phone:
39-075-585-3409. Fax: 39-075-585-3400. E-mail: tissi{at}unipg.it.
Infection and Immunity, September 1999, p. 4545-4550, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Puliti, M., Uematsu, S., Akira, S., Bistoni, F., Tissi, L.
(2009). Toll-Like Receptor 2 Deficiency Is Associated with Enhanced Severity of Group B Streptococcal Disease. Infect. Immun.
77: 1524-1531
[Abstract]
[Full Text]
-
Navarro-Gonzalez, J. F., Mora-Fernandez, C.
(2008). The Role of Inflammatory Cytokines in Diabetic Nephropathy. J. Am. Soc. Nephrol.
19: 433-442
[Abstract]
[Full Text]
-
Puliti, M., von Hunolstein, C., Marangi, M., Bistoni, F., Tissi, L.
(2006). Experimental model of infection with non-toxigenic strains of Corynebacterium diphtheriae and development of septic arthritis. J Med Microbiol
55: 229-235
[Abstract]
[Full Text]
-
Tissi, L., Puliti, M., Bistoni, F., Mosci, P., Kozel, T. R., Vecchiarelli, A.
(2004). Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Inhibits the Progression of Group B Streptococcal Arthritis. Infect. Immun.
72: 6367-6372
[Abstract]
[Full Text]
-
Puliti, M., von Hunolstein, C., Bistoni, F., Orefici, G., Tissi, L.
(2004). Inhibition of Nitric Oxide Synthase Exacerbates Group B Streptococcus Sepsis and Arthritis in Mice. Infect. Immun.
72: 4891-4894
[Abstract]
[Full Text]
-
Sakurai, A., Okahashi, N., Nakagawa, I., Kawabata, S., Amano, A., Ooshima, T., Hamada, S.
(2003). Streptococcus pyogenes Infection Induces Septic Arthritis with Increased Production of the Receptor Activator of the NF-{kappa}B Ligand. Infect. Immun.
71: 6019-6026
[Abstract]
[Full Text]
-
Okahashi, N., Sakurai, A., Nakagawa, I., Fujiwara, T., Kawabata, S., Amano, A., Hamada, S.
(2003). Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-{kappa}B Ligand Expression in Mouse Osteoblastic Cells. Infect. Immun.
71: 948-955
[Abstract]
[Full Text]
-
Puliti, M., von Hunolstein, C., Verwaerde, C., Bistoni, F., Orefici, G., Tissi, L.
(2002). Regulatory Role of Interleukin-10 in Experimental Group B Streptococcal Arthritis. Infect. Immun.
70: 2862-2868
[Abstract]
[Full Text]
-
de Coupade, C., Ajuebor, M. N., Russo-Marie, F., Perretti, M., Solito, E.
(2001). Cytokine Modulation of Liver Annexin 1 Expression during Experimental Endotoxemia. Am. J. Pathol.
159: 1435-1443
[Abstract]
[Full Text]
-
Call, D. R., Nemzek, J. A., Ebong, S. J., Bolgos, G. L., Newcomb, D. E., Remick, D. G.
(2001). Ratio of Local to Systemic Chemokine Concentrations Regulates Neutrophil Recruitment. Am. J. Pathol.
158: 715-721
[Abstract]
[Full Text]
-
Puliti, M., Bistoni, F., von Hunolstein, C., Orefici, G., Tissi, L.
(2001). Severity of Group B Streptococcal Arthritis in Selected Strains of Laboratory Mice. Infect. Immun.
69: 551-555
[Abstract]
[Full Text]